SHPGY Related Rumors
-
BioMarin (BMRN) Higher as Takeover Chatter Swirls
-
Shire (SHPGY) May Have Bid for Cubist (CBST) at $44.50/Share
-
Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)
-
Buckingham Research Maintains a 'Neutral' on Shire (SHPGY); Dead Money Near-Term, But Could Become Attractive Takeover Target
-
Shire plc (SHPGY) Higher On AstraZeneca Takeover Rumors
-
Shire plc (SHPGY) Higher on Pfizer Takeover Rumors
-
New River Pharmaceuticals (NRPH) Higher on Merger Chatter
-
Shire Pharmaceutical (SHPGY) implied volatility below average at 27
-
Dow Jones Reports a UK Newspaper says AstraZeneca (AZN) May Look to Acquire Shire (SHPGY)
-
FDA Comments on NOVN Patch More Upbeat Today Ahead of Vote
-
SHPGY Said Goldman Sachs Group Looking To Acquire 19.65M Shares
-
SHPGY Comments on BRL Speculation
Back to SHPGY Stock Lookup
